Met Life Investment Management, LLC Standard Biotools Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 181,262 shares of LAB stock, worth $242,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,262
Previous 120,977
49.83%
Holding current value
$242,891
Previous $130,000
66.92%
% of portfolio
0.0%
Previous 0.0%
Shares
42 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$102 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$78.6 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.8 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.5 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $105M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...